'Cycling' antibiotics might help combat resistance, study suggests

September 26, 2013 by Dennis Thompson, Healthday Reporter
'Cycling' antibiotics might help combat resistance, study suggests
Alternating drugs could extend their life and effectiveness, researchers say.

(HealthDay)—Doctors might be able to overcome antibiotic-resistant bacteria by swapping out the antibiotics used to treat a patient, providing a "one-two" punch that keeps the germs reeling, a new Danish study suggests.

The strategy relies on a concept called "collateral sensitivity," in which that become resistant to one antibiotic also become more vulnerable to other antibiotics.

The researchers argue that by swapping between antibiotics that play well off each other, doctors can stay one step ahead of bacteria and continuously avoid resistance.

"You cycle between drugs that have reciprocal sensitivities," explained study co-author Morten Sommer, a lead researcher with the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark.

"If you become resistant to drug A, you will become more sensitive to drug B. That way, you can cycle between drug A and drug B without increasing resistance in the long term," he added.

The U.S. Centers for Disease Control and Prevention recently declared antibiotic-resistant bacteria one of America's most serious , estimating that more than 2 million people are sickened and at least 23,000 die every year due to antibiotic-. Doctors are finding it increasingly hard to fight some infections because many antibiotics have become useless against bacteria that have developed resistance to the drugs.

The new study was published Sept. 25 in the journal Science Translational Medicine .

The concept of collateral sensitivity has been around since the 1950s, but never received much attention, Sommer said.

"I think basically it was discovered during the golden age of antibiotic development," he said. "There were coming onto the market all the time, and there wasn't the need that there is today for a strategy to counter resistance."

To test the concept, Sommer and his research team exposed E. coli bacteria to 23 different commonly used antibiotics, allowing the to develop resistance. Then they tested how each of the now-resistant bacteria responded to other antibiotics.

The researchers found that most antibiotics on the market can be "paired" with another antibiotic. As resistance to the first drug increases, the bacteria become more vulnerable to the other drug. In other cases, antibiotics can be used in a sequential deployment of three or four different drugs.

As many as 200 already approved antibiotics could be used in this manner, with one medication playing off one or more others, Sommer said.

"The timing will depend on the resistance development that's occurring in the patient," he said. "A doctor will want to cycle the drug when patient improvement slows or stops."

This cycling strategy could be most helpful for patients suffering from long-term infectious diseases like tuberculosis or cystic fibrosis, Sommer suggested. "We think this treatment strategy will be primarily relevant when the patient is suffering a chronic infection," he said. "In those cases, the infection continues for a long time, which allows for resistance to build."

Collateral sensitivity cycling also could help increase the life span of many antibiotics, allowing them to remain useful tools for longer periods, the study authors added.

The researchers said their findings need further testing in animals and then in patient clinics.

This strategy likens bacteria to science fiction villains that automatically adapt to any weapon used against them, said Victoria Richards, associate professor of medical sciences at Quinnipiac University's Frank H. Netter MD School of Medicine, in North Haven, Conn.

"Any antibiotic is a weapon against a bacteria," she said. "With this approach, they could break that cycle of bacteria trying to adapt to our weapons."

Richards said doctors and hospitals might want to consider implementing this sort of cycling strategy as soon as possible, as part of their overall plan to prevent resistance.

"It's not like these are experimental antibiotics," she said. "They are commonly used, and can be used in response to the bacteria responding to other antibiotics. It's trying to keep one step ahead of the bacteria, by looking in a different way at that have been used for decades."

Explore further: CDC sounds alarm on antibiotic-resistant bacteria

More information: For more on antibiotic resistance, visit the U.S. Centers for Disease Control and Prevention.

Related Stories

CDC sounds alarm on antibiotic-resistant bacteria

September 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday by federal health ...

Bacterial 'autopsy' could speed antibiotic discovery: study

September 20, 2013
(HealthDay)—Scientists say they've found a quicker way to analyze chemicals with bacteria-killing abilities in an advance they hope will speed the development of new antibiotics.

New hypothesis: Why bacteria are becoming increasingly more resistant to antibiotics

March 7, 2013
According to his theory, bacteria that are non-resistant to antibiotics acquire said resistance accidentally because they take up the DNA of others that are resistant, due to the stress to which they are subjected.

Research shows novel way in which Salmonella can resist antibiotics and antibacterial soaps

July 24, 2013
Salmonella bacteria – most frequently spread to humans by infected food – that develop a resistance to one group of antibiotics are also less susceptible to killing by other, unrelated antibiotics and a biocide used in ...

Academies urge new measures against drug-resistant bacteria

June 17, 2013
Fewer and fewer antibiotics are available for an increasing number of infections caused by antibiotic-resistant bacteria. As a result, it is becoming increasingly difficult to treat infected patients successfully. The Academy ...

Recommended for you

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.